Quick Answer
QIAGEN N.V. reported Gross Profit of $1.30 billion for fiscal year 2025.
QIAGEN N.V. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $1.30B | +34.3% |
| 2024 | $967.35M | -21.6% |
| 2023 | $1.23B | -10.9% |
| 2022 | $1.38B | -4.6% |
| 2021 | $1.45B | +17.7% |
| 2020 | $1.23B | +22.6% |
| 2019 | $1.01B | +0.4% |
| 2018 | $1.00B | +8.5% |
| 2017 | $922.56M | +9.2% |
| 2016 | $844.65M | +2.2% |
| 2015 | $826.66M | -4.5% |
| 2014 | $865.21M | +6.1% |
| 2013 | $815.49M | -1.0% |
| 2012 | $824.02M | +9.9% |
| 2011 | $749.81M | +4.8% |
| 2010 | $715.56M | +7.3% |
| 2009 | $667.07M | +11.2% |
| 2008 | $599.69M | — |
- QIAGEN N.V. showed an increase of +34.3% in Gross Profit compared to the prior fiscal year.
- Over the 2008–2025 period, QIAGEN N.V.’s gross profit has grown by 116.7% (from $599.69 million to $1.30 billion).
- The most recent figure is from QIAGEN N.V.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: